Diffuse large B cell lymphoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mohamed riad (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AS}} {{AHS}} | {{CMG}}; {{AE}} {{AS}} {{AHS}} | ||
==Overview== | ==Overview== | ||
Diffuse large B cell lymphoma is the most common type of [[non-Hodgkin lymphoma]] | [[Diffuse large B cell lymphoma]] is considered the most common type of [[non-Hodgkin lymphoma]] in adult population. The annual [[Incidence (epidemiology)|incidence]] is about 150,000 people worldwide. It mainly affects older individuals, with a median age of diagnosis at approximately 70 years old; however, it may affect children and young adults in rare cases. | ||
===Incidence=== | ===Incidence=== | ||
Diffuse large B cell lymphoma is the most common type of [[non-Hodgkin lymphoma]] | [[Diffuse large B cell lymphoma]] is considered the most common type of [[non-Hodgkin lymphoma]] in adult population representing approximately 30% of [[non-Hodgkin lymphoma]] cases.<ref name="Blood1997">{{cite journal |pmid=9166827 |year=1997 |title=A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project |journal=Blood |volume=89 |issue=11 |pages=3909–18 |url=http://www.bloodjournal.org/content/89/11/3909 }}</ref> The annual [[Incidence (epidemiology)|incidence]] is about 150,000 people worldwide.<ref name="pmid33657296">{{cite journal| author=Sehn LH, Salles G| title=Diffuse Large B-Cell Lymphoma. | journal=N Engl J Med | year= 2021 | volume= 384 | issue= 9 | pages= 842-858 | pmid=33657296 | doi=10.1056/NEJMra2027612 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33657296 }}</ref> | ||
===Age=== | ===Age=== | ||
[[Diffuse large B cell lymphoma]] mainly affects older individuals, with a [[median]] age of [[diagnosis]] at approximately 70 years of age;<ref name="Smith2011">{{cite journal |doi=10.1038/bjc.2011.450 |pmid=22045184 |pmc=3242607 |title=Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network |journal=British Journal of Cancer |volume=105 |issue=11 |pages=1684–92 |year=2011 |last1=Smith |first1=A |last2=Howell |first2=D |last3=Patmore |first3=R |last4=Jack |first4=A |last5=Roman |first5=E }}</ref> however, it may affect children and young adults in rare cases.<ref name="Smith2010">{{cite journal |doi=10.1111/j.1365-2141.2009.08010.x |pmid=19958356 |pmc=3066245 |title=The Haematological Malignancy Research Network (HMRN): A new information strategy for population based epidemiology and health service research |journal=British Journal of Haematology |volume=148 |issue=5 |pages=739–53 |year=2010 |last1=Smith |first1=Alexandra |last2=Roman |first2=Eve |last3=Howell |first3=Debra |last4=Jones |first4=Richard |last5=Patmore |first5=Russell |last6=Jack |first6=Andrew |author7=Haematological Malignancy Research Network }}</ref> | |||
==References== | ==References== | ||
Revision as of 15:45, 14 April 2021
|
Diffuse large B cell lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diffuse large B cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Diffuse large B cell lymphoma epidemiology and demographics |
|
FDA on Diffuse large B cell lymphoma epidemiology and demographics |
|
CDC on Diffuse large B cell lymphoma epidemiology and demographics |
|
Diffuse large B cell lymphoma epidemiology and demographics in the news |
|
Blogs on Diffuse large B cell lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Diffuse large B cell lymphoma |
|
Risk calculators and risk factors for Diffuse large B cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2] Anila Hussain, MD [3]
Overview
Diffuse large B cell lymphoma is considered the most common type of non-Hodgkin lymphoma in adult population. The annual incidence is about 150,000 people worldwide. It mainly affects older individuals, with a median age of diagnosis at approximately 70 years old; however, it may affect children and young adults in rare cases.
Incidence
Diffuse large B cell lymphoma is considered the most common type of non-Hodgkin lymphoma in adult population representing approximately 30% of non-Hodgkin lymphoma cases.[1] The annual incidence is about 150,000 people worldwide.[2]
Age
Diffuse large B cell lymphoma mainly affects older individuals, with a median age of diagnosis at approximately 70 years of age;[3] however, it may affect children and young adults in rare cases.[4]
References
- ↑ "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project". Blood. 89 (11): 3909–18. 1997. PMID 9166827.
- ↑ Sehn LH, Salles G (2021). "Diffuse Large B-Cell Lymphoma". N Engl J Med. 384 (9): 842–858. doi:10.1056/NEJMra2027612. PMID 33657296 Check
|pmid=value (help). - ↑ Smith, A; Howell, D; Patmore, R; Jack, A; Roman, E (2011). "Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network". British Journal of Cancer. 105 (11): 1684–92. doi:10.1038/bjc.2011.450. PMC 3242607. PMID 22045184.
- ↑ Smith, Alexandra; Roman, Eve; Howell, Debra; Jones, Richard; Patmore, Russell; Jack, Andrew; Haematological Malignancy Research Network (2010). "The Haematological Malignancy Research Network (HMRN): A new information strategy for population based epidemiology and health service research". British Journal of Haematology. 148 (5): 739–53. doi:10.1111/j.1365-2141.2009.08010.x. PMC 3066245. PMID 19958356.